New Products

NEW YORK — WebMD Health Corp. on Tuesday launched the WebMD Allergy app for the iPhone, a mobile resource that empowers consumers to take control of their allergies. 

"The WebMD Allergy app provides consumers with accurate and personalized weather-related allergy information to help them proactively manage their allergy conditions," stated Michael Smith, WebMD chief medical editor. "WebMD's trusted allergy information is delivered through an innovative mobile app to help consumers be better prepared to face the day."

SHELTON, Conn. — Energizer Personal Care has introduced a line of wipes designed for use after sex.

Energizer announced Tuesday the introduction of Fresh + Sexy wipes by Playtex, described as a before-and-after intimate wipe to help couples feel clean after sexual activity.

Cool Whip is offering a new way for consumers to top off their sweet treats: easy-to-spread Cool Whip frosting. Available in chocolate, cream cheese and vanilla, the frosting is perfect for decorating desserts and piping, and the brand encourages bakers everywhere to "celebrate the everyday moments" with its latest whipped topping. 

ALLEGAN, Mich. — The Food and Drug Administration has approved a testosterone gel product made by Perrigo, the drug maker said Tuesday.

Perrigo announced the approval of the testosterone gel in the 1% strength for the treatment of men with low or no testosterone.

The drug is bioequivalent to AbbVie's AndroGel, which has annual sales of about $705 million, according to Symphony Health.

NEW YORK — Nespresso on Monday announced the addition of Linizio Lungo to its range of high-quality coffee. Linizio Lungo is a rich, smooth, velvety coffee with mild character and sweet round cereal notes, expressly created for America's morning coffee drinker.

Created to provide a longer cup of coffee, Linizio Lungo joins the family of existing Nespresso Lungos: Vivalto Lungo, Decaffeinato Lungo and Fortissio Lungo.

SILVER SPRING, Md. — The Food and Drug Administration has approved a generic version of a cancer drug in a move that the agency said would help relieve shortages.

The FDA announced the approval of Sun Pharma Global's doxorubicin hydrochloride liposome injection, a generic version of Johnson & Johnson's Doxil. The drug is currently on the agency's list of drugs experiencing shortages.

ALLEGAN, Mich. — Drug maker Perrigo has launched a generic drug for treating problems of the scalp, the company said.

Perrigo announced the launch of clobetasol emulsion propionate foam in the 0.05% strength, a generic version of GlaxoSmithKline's Olux-E. The drug is used to treat moderate to severe dermatosis of the scalp.

CAMP HILL, Pa. — Jesse’s Girl Cosmetics has announced the expansion of its JulieG Collection for nails.